X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Closed-End Funds | 6 | P - Purchase | $50.00 | +1,402,000 | 1,402,000 | % | +$70,100,000 | |||||
| 2 D | 2026-04-29 | SPGI | S&P Global Inc. | Consumer Credit Reporting, Collection Agencies | 2 | P - Purchase | $413.89 | +4,822 | 30,183 | +19% | +$1,995,756 | |||||
| 3 | 2026-05-01 | GEHC | Ge Healthcare Technologies Inc. | X-Ray Apparatus & Tubes & Related Irradiation Apparatus | 3 | P - Purchase | $60.27 | +9,229 | 440,827 | +2% | +$556,200 | |||||
| 3 | 2026-04-29 | CCFN | Muncy Columbia Financial Corp | State Commercial Banks | 3 | P - Purchase | $66.84 | +2,048 | 34,661 | +6% | +$136,889 | |||||
| 9 | 2026-04-28 | AVBC | Avidia Bancorp, Inc. | Savings Institutions, Not Federally Chartered | 8 | P - Purchase | $19.98 | +20,271 | 374,024 | +6% | +$405,010 | |||||
| 5 DM | 2026-04-28 | IPX | Iperionx Ltd | Miscellaneous Metal Ores | 3 | P - Purchase | $3.99 | +1,299,212 | 39,712,130 | +3% | +$5,184,906 | |||||
| 8 M | 2026-04-28 | ZBIO | Zenas Biopharma, Inc. | Pharmaceutical Preparations | 4 | P - Purchase | $19.67 | +445,613 | 5,051,743 | +10% | +$8,766,667 | |||||
| 4 | 2026-04-27 | PFBX | Peoples Financial Corp /Ms/ | State Commercial Banks | 3 | P - Purchase | $20.65 | +47,525 | 1,183,791 | +4% | +$981,463 | |||||
| 2 | 2026-04-27 | XE | X-Energy, Inc. | Fabricated Plate Work (Boiler Shops) | 2 | P - Purchase | $23.00 | +11,200 | 330,984 | +4% | +$257,600 | |||||
| 3 | 2026-04-28 | CHTR | Charter Communications, Inc. /Mo/ | Cable & Other Pay Television Services | 3 | P - Purchase | $173.09 | +13,664 | 244,390 | +6% | +$2,365,149 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-04-27 | LASE | Laser Photonics Corp | Lu Qing | Dir | P - Purchase | $0.68 | +69,000 | 83,812 | +466% | +$46,860 | |||||
2026-04-30 | CBK | Commercial Bancgroup, Inc. | Metheny Philip J. | EVP, CFO | P - Purchase | $29.02 | +3,300 | 12,732 | +35% | +$95,760 | ||||||
| D | 2026-05-01 | AVLN | Avalyn Pharma Inc. | Carroll Jill | Dir | P - Purchase | $18.00 | +277,778 | 2,186,562 | +15% | +$5,000,004 | |||||
| D | 2026-05-01 | AVLN | Avalyn Pharma Inc. | Sr One Capital Management, LLC | 10% | P - Purchase | $18.00 | +555,555 | 3,308,649 | +20% | +$9,999,990 | |||||
2026-04-30 | SBMT | Silver Bow Mining Corp. | Naugle Charles Travis | CEO | P - Purchase | $9.88 | +5,000 | 148,799 | +3% | +$49,409 | ||||||
| M | 2026-04-29 | AXR | Amrep Corp. | Dahl James H | 10% | P - Purchase | $27.78 | +8,000 | 983,998 | +1% | +$222,257 | |||||
2026-04-30 | CR | Crane Co | Lynch Susan D | Dir | P - Purchase | $177.38 | +150 | 370 | +68% | +$26,607 | ||||||
2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Botta Nicholas Anthony | Trustee | P - Purchase | $50.00 | +250,000 | 250,000 | New | +$12,500,000 | ||||||
| D | 2026-04-29 | AUID | Authid Inc. | Garchik Stephen Jeffrey | Dir, 10% | P - Purchase | $1.25 | +120,482 | 1,643,481 | +8% | +$150,000 | |||||
2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Coussin Halit | Chief Compliance Officer | P - Purchase | $50.00 | +200,000 | 200,000 | New | +$10,000,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-04-27 | LASE | Laser Photonics Corp | Lu Qing | Dir | P - Purchase | $0.68 | +69,000 | 83,812 | +466% | +$46,860 | |||||
| D | 2026-04-29 | AUID | Authid Inc. | Garchik Stephen Jeffrey | Dir, 10% | P - Purchase | $1.25 | +120,482 | 1,643,481 | +8% | +$150,000 | |||||
| D | 2026-04-29 | AUID | Authid Inc. | Jisser Ken | Dir | P - Purchase | $1.25 | +30,120 | 122,245 | +33% | +$37,499 | |||||
2026-04-14 | SUNE | Sunation Energy, Inc. | Brennan James Robert | CFO | P - Purchase | $1.77 | +123,254 | 123,269 | >999% | +$218,160 | ||||||
2026-04-14 | SUNE | Sunation Energy, Inc. | Maskin Scott | CEO, 10% | P - Purchase | $1.77 | +554,712 | 554,736 | >999% | +$981,840 | ||||||
2026-04-30 | NWWP | New Peoples Bankshares Inc | Cox John D | Dir | P - Purchase | $3.88 | +8,570 | 870,359 | +1% | +$33,252 | ||||||
| D | 2026-04-29 | IBATF | International Battery Metals Ltd. | Warnock Jacob Aaron | Dir, 10% | P - Purchase | $0.08 | +34,315,465 | 143,641,569 | +31% | +$2,745,237 | |||||
2026-04-28 | FCHL | Fitness Champs Holdings Ltd | Hrt Financial LP | 10% | P - Purchase | $0.15 | +239,692 | 420,917 | +132% | +$35,714 | ||||||
| A | 2026-04-29 | CMPX | Compass Therapeutics, Inc. | Lerner Neil | CHIEF ACCOUNTING OFFICER | P - Purchase | $1.89 | +15,000 | 397,500 | +4% | +$28,350 | |||||
| A | 2026-04-29 | CMPX | Compass Therapeutics, Inc. | Anderman Jonathan | GC | P - Purchase | $1.89 | +25,000 | 196,000 | +15% | +$47,250 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-05-01 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $119.91 | -209,157 | 2,719,420 | -7% | -$25,080,696 | ||||||
2026-05-01 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $119.91 | -1,284,876 | 7,607,123 | -14% | -$154,073,682 | ||||||
2026-04-30 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $117.84 | -6,564 | 2,737,300 | 0% | -$773,502 | ||||||
| D | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | CFO | S - Sale+OE | $71.37 | -12,500 | 97,994 | -11% | -$892,125 | |||||
| D | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | S - Sale+OE | $71.50 | -78,333 | 0 | -100% | -$5,600,701 | |||||
2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Turtle Cameron | CEO | S - Sale | $71.37 | -15,000 | 612,540 | -2% | -$1,070,507 | ||||||
2026-04-30 | ADBE | Adobe Inc. | Forusz Jillian | SVP, CAO | S - Sale | $246.25 | -755 | 3,521 | -18% | -$185,915 | ||||||
2026-05-01 | CCB | Coastal Financial Corp | Hamilton Brian T | Pres of CCBX | S - Sale | $75.44 | -3,079 | 74,571 | -4% | -$232,273 | ||||||
| D | 2026-05-01 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $33.40 | -9,000 | 81,389 | -10% | -$300,560 | |||||
| D | 2026-04-30 | INDI | Indie Semiconductor, Inc. | Aoki Ichiro | Pres | S - Sale+OE | $4.40 | -100,000 | 3,745,531 | -3% | -$440,240 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-05-01 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $119.91 | -209,157 | 2,719,420 | -7% | -$25,080,696 | ||||||
2026-05-01 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $119.91 | -1,284,876 | 7,607,123 | -14% | -$154,073,682 | ||||||
2026-04-30 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $117.84 | -6,564 | 2,737,300 | 0% | -$773,502 | ||||||
2026-04-29 | PRKS | United Parks & Resorts Inc. | Miller Kyle Robert | See Remarks | F - Tax | $34.36 | -43 | 39,495 | 0% | -$1,477 | ||||||
2026-04-29 | PRKS | United Parks & Resorts Inc. | Dold Christopher | Chief Zoological Officer | F - Tax | $34.36 | -83 | 52,062 | 0% | -$2,852 | ||||||
| D | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | CFO | M - OptEx | $14.50 | +12,500 | 97,994 | +15% | +$181,250 | |||||
| D | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | CFO | S - Sale+OE | $71.37 | -12,500 | 97,994 | -11% | -$892,125 | |||||
| D | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | M - OptEx | $27.46 | +78,333 | 0 | -100% | +$2,151,024 | |||||
| D | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | S - Sale+OE | $71.50 | -78,333 | 0 | -100% | -$5,600,701 | |||||
2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Turtle Cameron | CEO | S - Sale | $71.37 | -15,000 | 612,540 | -2% | -$1,070,507 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |